1. Home
  2. MSBI vs LXRX Comparison

MSBI vs LXRX Comparison

Compare MSBI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • LXRX
  • Stock Information
  • Founded
  • MSBI 1881
  • LXRX 1995
  • Country
  • MSBI United States
  • LXRX United States
  • Employees
  • MSBI N/A
  • LXRX N/A
  • Industry
  • MSBI Major Banks
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSBI Finance
  • LXRX Health Care
  • Exchange
  • MSBI Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • MSBI 378.1M
  • LXRX 428.8M
  • IPO Year
  • MSBI 2016
  • LXRX 2000
  • Fundamental
  • Price
  • MSBI $16.92
  • LXRX $1.55
  • Analyst Decision
  • MSBI Hold
  • LXRX Buy
  • Analyst Count
  • MSBI 3
  • LXRX 5
  • Target Price
  • MSBI $20.67
  • LXRX $3.23
  • AVG Volume (30 Days)
  • MSBI 129.6K
  • LXRX 2.5M
  • Earning Date
  • MSBI 10-23-2025
  • LXRX 11-11-2025
  • Dividend Yield
  • MSBI 7.37%
  • LXRX N/A
  • EPS Growth
  • MSBI N/A
  • LXRX N/A
  • EPS
  • MSBI N/A
  • LXRX N/A
  • Revenue
  • MSBI $224,320,000.00
  • LXRX $58,432,000.00
  • Revenue This Year
  • MSBI $27.04
  • LXRX $67.21
  • Revenue Next Year
  • MSBI N/A
  • LXRX N/A
  • P/E Ratio
  • MSBI N/A
  • LXRX N/A
  • Revenue Growth
  • MSBI N/A
  • LXRX 1504.83
  • 52 Week Low
  • MSBI $14.79
  • LXRX $0.28
  • 52 Week High
  • MSBI $28.08
  • LXRX $2.18
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 38.07
  • LXRX 73.01
  • Support Level
  • MSBI $16.61
  • LXRX $1.28
  • Resistance Level
  • MSBI $17.25
  • LXRX $1.42
  • Average True Range (ATR)
  • MSBI 0.46
  • LXRX 0.09
  • MACD
  • MSBI -0.11
  • LXRX 0.03
  • Stochastic Oscillator
  • MSBI 16.49
  • LXRX 100.00

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: